80 related articles for article (PubMed ID: 24618874)
21. Are branched chain fatty acids the natural substrates for P450(BM3)?
Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
[TBL] [Abstract][Full Text] [Related]
22. P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity.
Zhang K; El Damaty S; Fasan R
J Am Chem Soc; 2011 Mar; 133(10):3242-5. PubMed ID: 21341707
[TBL] [Abstract][Full Text] [Related]
23. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
24. A-ring ortho-specific monohydroxylation of daidzein by cytochrome P450s of Nocardia farcinica IFM10152.
Choi KY; Kim TJ; Koh SK; Roh CH; Pandey BP; Lee N; Kim BG
Biotechnol J; 2009 Nov; 4(11):1586-95. PubMed ID: 19918785
[TBL] [Abstract][Full Text] [Related]
25. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
de Visser SP; Shaik S
J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
[TBL] [Abstract][Full Text] [Related]
26. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
27. Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.
Wong TS; Arnold FH; Schwaneberg U
Biotechnol Bioeng; 2004 Feb; 85(3):351-8. PubMed ID: 14748091
[TBL] [Abstract][Full Text] [Related]
28. Products of cytochrome P450(BioI) (CYP107H1)-catalyzed oxidation of fatty acids.
Cryle MJ; Matovic NJ; De Voss JJ
Org Lett; 2003 Sep; 5(18):3341-4. PubMed ID: 12943422
[TBL] [Abstract][Full Text] [Related]
29. Engineering of recombinant E. coli cells co-expressing P450pyrTM monooxygenase and glucose dehydrogenase for highly regio- and stereoselective hydroxylation of alicycles with cofactor recycling.
Pham SQ; Gao P; Li Z
Biotechnol Bioeng; 2013 Feb; 110(2):363-73. PubMed ID: 22886996
[TBL] [Abstract][Full Text] [Related]
30. Omega oxygenases: nonheme-iron enzymes and P450 cytochromes.
Coon MJ
Biochem Biophys Res Commun; 2005 Dec; 338(1):378-85. PubMed ID: 16165094
[TBL] [Abstract][Full Text] [Related]
31. Efficient stereo- and regioselective hydroxylation of alkanes catalysed by a bulky polyoxometalate.
Kamata K; Yonehara K; Nakagawa Y; Uehara K; Mizuno N
Nat Chem; 2010 Jun; 2(6):478-83. PubMed ID: 20489717
[TBL] [Abstract][Full Text] [Related]
32. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
33. Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3.
Münzer DF; Meinhold P; Peters MW; Feichtenhofer S; Griengl H; Arnold FH; Glieder A; de Raadt A
Chem Commun (Camb); 2005 May; (20):2597-9. PubMed ID: 15900339
[TBL] [Abstract][Full Text] [Related]
34. Development of colorimetric HTS assay of cytochrome p450 for ortho-specific hydroxylation, and engineering of CYP102D1 with enhanced catalytic activity and regioselectivity.
Choi KY; Jung EO; Yun H; Yang YH; Kazlauskas RJ; Kim BG
Chembiochem; 2013 Jul; 14(10):1231-8. PubMed ID: 23780920
[TBL] [Abstract][Full Text] [Related]
35. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
36. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
37. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
[TBL] [Abstract][Full Text] [Related]
38. [Factors determining the selectivity of cytochrome P-450-catalyzed alkane oxidation].
Karasevich EI; Khenkin AM
Biokhimiia; 1986 Sep; 51(9):1454-8. PubMed ID: 3768443
[TBL] [Abstract][Full Text] [Related]
39. Selectivity in a barren landscape: the P450(BioI)-ACP complex.
Cryle MJ
Biochem Soc Trans; 2010 Aug; 38(4):934-9. PubMed ID: 20658980
[TBL] [Abstract][Full Text] [Related]
40. Regioselective hydroxylation of C(12)-C(15) fatty acids with fluorinated substituents by cytochrome P450 BM3.
Chiang CH; Ramu R; Tu YJ; Yang CL; Ng KY; Luo WI; Chen CH; Lu YY; Liu CL; Yu SS
Chemistry; 2013 Oct; 19(41):13680-91. PubMed ID: 24092541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
